|
DUR-928, an endogenous regulatory molecule, exhibits
anti-inflammatory and antifibrotic activity in a mouse model of NASH
|
|
|
Reported by Jules Levin
AASLD's Emerging Trends in NAFLD, Washington DC, March 17-18, 2017
Mee J. Kim, WeiQi Lin, DURECT Corporation, Cupertino, CA, USA
![0526171](../images/052617/052617-1/0526171.gif)
![0526172](../images/052617/052617-1/0526172.gif)
![0526173](../images/052617/052617-1/0526173.gif)
![0526174](../images/052617/052617-1/0526174.gif)
![0526175](../images/052617/052617-1/0526175.gif)
![0526176](../images/052617/052617-1/0526176.gif)
|
|
|
|
|
|
|